Early relapse within 18 months (ER18) is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma.

Wenqiang YanJingyu XuHuishou FanLingna LiJian CuiChenxing DuShuhui DengWeiwei SuiLian XuMu HaoKenneth C AndersonDehui ZouLugui QiuGang An

Published in: Cancer (2023)

Collectively, this study concludes that ER18 is a simple and dynamic prognostic predictor in MM. In addition to static risk assessment, dynamic risk plays an important role in survival prediction.

Keyphrases

risk assessment
multiple myeloma
estrogen receptor
endoplasmic reticulum
breast cancer cells
human health